Form 4 holding
Director
Spyre Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 27,360
- Estimated value
- $1,005,838
- Report date
- 06 Nov 2024
- Price
- $36.76
- Ownership
- By Sessions LLC
Jeffrey W. Albers - Director at Spyre Therapeutics, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- Director
- Issuer Symbol
- SYRE on Nasdaq
- All Insider Reports
- All Insider Reports
There are no Buy or Sell transactions made by Jeffrey W. Albers since 27 May 2025
Holdings reported by Jeffrey W. Albers for Spyre Therapeutics, Inc.
Form 4 holding
Director
Spyre Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 25,000
- Estimated value
- Report date
- 29 May 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Jeffrey W. Albers for Spyre Therapeutics, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.